Medicinal cannabis: Patient access and clinical evidence
In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...
Heading off patient harm from medicines
Medicine adherence, deprescribing and establishing systems to prevent error recurrence are all part of the pharmacist’s calling to protect patient safety.
Pharmacists, as custodians of...
Consumers want to see pharmacy services expand
Consumers desire greater specialisation and increased services from the pharmacy profession, which should be front of mind in community pharmacy practice.
Consumer input into pharmacy...
Activate more pharmacist immunisers now
The thousands of community pharmacies assessed as suitable COVID-19 vaccination sites must be activated now.
NDSS changes to assist in diabetes management
Changes to the Australian Government’s National Diabetes Services Scheme (NDSS) took effect on 1 December, altering the range and price of certain products available...
Hot topics at the 2019 FIP Congress
Medicine access, technological disruption to traditional care models, ethical dilemmas and gender equity dominated the program for the 79th International Pharmacy Federation (FIP) Congress.
The...













